| Product Code: ETC8853918 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the Philippines saw a significant increase in ursodeoxycholic acid import shipments, with top exporters being Singapore, China, Switzerland, Taiwan, and Japan. The market concentration, as measured by the HHI, shifted from moderate to high concentration, indicating a more competitive landscape. Despite a negative CAGR from 2020 to 2024, there was a notable growth rate of 8.98% from 2023 to 2024, suggesting a potential uptrend in demand for this pharmaceutical product in the Philippines.

The ursodeoxycholic acid market is steadily growing due to its clinical use in treating gallstones and liver diseases. It is commonly prescribed by gastroenterologists and hepatologists, with imported brands dominating the pharmaceutical supply chain. Awareness among patients and an increase in lifestyle-related hepatic disorders contribute to rising demand.
The market for urothelial cancer drugs is expanding thanks to investments in oncology infrastructure and the introduction of targeted and immuno-oncology therapies. Specialist centers in Metro Manila are offering advanced drugs, improving patient access and treatment options.
This bile acid treatment market is constrained by low liver disease screening rates, import reliance for finished formulations, and limited availability in public hospitals. Cost is a major barrier for long-term therapy, and awareness among primary care physicians remains inconsistent.
Ursodeoxycholic acid, widely used in treating liver diseases, is in growing demand due to rising cases of hepatobiliary disorders. Investment opportunities lie in pharmaceutical importation, distribution networks, and partnership with hepatology clinics for awareness and adoption.
Ursodeoxycholic acid (UDCA), used in liver disease treatment, is regulated as a prescription drug by the FDA Philippines. Manufacturers and importers must provide clinical evidence, quality assurance documentation, and pharmacovigilance data for market approval. UDCA is included in the Philippine Essential Medicines List, making it available in government hospitals and under PhilHealths outpatient drug benefit packages.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Ursodeoxycholic Acid Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Ursodeoxycholic Acid Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Ursodeoxycholic Acid Market - Industry Life Cycle |
3.4 Philippines Ursodeoxycholic Acid Market - Porter's Five Forces |
3.5 Philippines Ursodeoxycholic Acid Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Ursodeoxycholic Acid Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Ursodeoxycholic Acid Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of liver diseases in the Philippines |
4.2.2 Growing awareness about the benefits of ursodeoxycholic acid in treating liver disorders |
4.2.3 Rise in disposable income leading to higher healthcare expenditure in the country |
4.3 Market Restraints |
4.3.1 High cost of ursodeoxycholic acid medication |
4.3.2 Limited availability and accessibility of specialized healthcare facilities in certain regions of the Philippines |
5 Philippines Ursodeoxycholic Acid Market Trends |
6 Philippines Ursodeoxycholic Acid Market, By Types |
6.1 Philippines Ursodeoxycholic Acid Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Ursodeoxycholic Acid Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Ursodeoxycholic Acid Market Revenues & Volume, By Synthetic UDCA, 2021- 2031F |
6.1.4 Philippines Ursodeoxycholic Acid Market Revenues & Volume, By Extraction UDCA, 2021- 2031F |
6.2 Philippines Ursodeoxycholic Acid Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Ursodeoxycholic Acid Market Revenues & Volume, By Pharmacy, 2021- 2031F |
6.2.3 Philippines Ursodeoxycholic Acid Market Revenues & Volume, By Health Products, 2021- 2031F |
7 Philippines Ursodeoxycholic Acid Market Import-Export Trade Statistics |
7.1 Philippines Ursodeoxycholic Acid Market Export to Major Countries |
7.2 Philippines Ursodeoxycholic Acid Market Imports from Major Countries |
8 Philippines Ursodeoxycholic Acid Market Key Performance Indicators |
8.1 Number of liver disease diagnoses in the Philippines |
8.2 Percentage of healthcare professionals recommending ursodeoxycholic acid |
8.3 Adoption rate of ursodeoxycholic acid as a treatment option among patients |
9 Philippines Ursodeoxycholic Acid Market - Opportunity Assessment |
9.1 Philippines Ursodeoxycholic Acid Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Ursodeoxycholic Acid Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Ursodeoxycholic Acid Market - Competitive Landscape |
10.1 Philippines Ursodeoxycholic Acid Market Revenue Share, By Companies, 2024 |
10.2 Philippines Ursodeoxycholic Acid Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |